Literature DB >> 33659023

Identification of Differently Expressed mRNAs in Atherosclerosis Reveals CDK6 Is Regulated by circHIPK3/miR-637 Axis and Promotes Cell Growth in Human Vascular Smooth Muscle Cells.

Le Kang1, Hao Jia1, Ben Huang1, Shuyang Lu1, Zhenhang Chen1, Jinqiang Shen1, Yunzeng Zou2, Chunsheng Wang1, Yongxin Sun1.   

Abstract

Atherosclerosis is the leading cause of heart disease and stroke, and one of the leading causes of death and disability worldwide. The phenotypic transformation of vascular smooth muscle cells (VSMCs) plays an important role in the pathological process of atherosclerosis. The present study aimed to identify differently expressed mRNAs in atherosclerosis by analyzing GSE6088 database. Our results revealed there were totally 467 increased and 490 decreased differential expressed genes (DEGs) in atherosclerosis. Bioinformatics analysis demonstrated that the DEGs substantially existed in pathways, including Glyoxylate and dicarboxylate metabolism, Tyrosine metabolism, Tryptophan metabolism, Beta-Alanine metabolism, Fatty acid biosynthesis and Starch and sucrose metabolism. Next, we constructed a protein-protein interaction (PPI) network to identify hub genes in atherosclerosis. Also, we identified CDK6 as a key regulator of atherosclerosis. In this study, we found that CDK6 knockdown suppressed HASMC and HUASMC cell proliferation. Circular RNA (CircRNA) is a non-coding RNA which is reported to have an unusual influence on tumorigenesis process and other aspects in the last few years. Previous studies showed circRNAs could act as miRNAs sponging in multiple biological processes. Bioinformatics prediction and luciferase analysis showed that CDK6 were targeted and regulated by circHIPK3/miR-637. Moreover, silencing circHIPK3 could also significantly induce the arrest and apoptosis of cell cycle. In conclusion, this study discovered the important regulatory role of circHIPK3 in the proliferation and apoptosis of VSMCs by influencing the miR-637/CDK6 axis.
Copyright © 2021 Kang, Jia, Huang, Lu, Chen, Shen, Zou, Wang and Sun.

Entities:  

Keywords:  CDK6; MiRNA-637; VSMCs; atherosclerosis; circHIPK3

Year:  2021        PMID: 33659023      PMCID: PMC7917241          DOI: 10.3389/fgene.2021.596169

Source DB:  PubMed          Journal:  Front Genet        ISSN: 1664-8021            Impact factor:   4.599


  7 in total

Review 1.  CircRNA-miRNA interactions in atherogenesis.

Authors:  Kind-Leng Tong; Ke-En Tan; Yat-Yuen Lim; Xin-Yi Tien; Pooi-Fong Wong
Journal:  Mol Cell Biochem       Date:  2022-05-23       Impact factor: 3.396

2.  CircHIPK3 Regulates Vascular Smooth Muscle Cell Calcification Via the miR-106a-5p/MFN2 Axis.

Authors:  Wen-Bo Zhang; You-Fei Qi; Zhan-Xiang Xiao; Hao Chen; Sa-Hua Liu; Zhen-Zhen Li; Zhao-Fan Zeng; Hong-Fei Wu
Journal:  J Cardiovasc Transl Res       Date:  2022-04-25       Impact factor: 4.132

Review 3.  Circular RNAs: regulators of vascular smooth muscle cells in cardiovascular diseases.

Authors:  Meichun Wu; Min Xun; Yuping Chen
Journal:  J Mol Med (Berl)       Date:  2022-03-07       Impact factor: 4.599

4.  MicroRNA-375-3p is implicated in carotid artery stenosis by promoting the cell proliferation and migration of vascular smooth muscle cells.

Authors:  Yuxia Yin; Zhen Cheng; Xiaoling Fu; Shishun Ji
Journal:  BMC Cardiovasc Disord       Date:  2021-10-26       Impact factor: 2.298

5.  Impact of CircRNAs on Ischemic Stroke.

Authors:  Miaomiao Liu; Xiaolin Liu; Maorong Zhou; Shao Guo; Kai Sun
Journal:  Aging Dis       Date:  2022-04-01       Impact factor: 6.745

6.  Identifying causal genes for stroke via integrating the proteome and transcriptome from brain and blood.

Authors:  Bang-Sheng Wu; Shu-Fen Chen; Shu-Yi Huang; Ya-Nan Ou; Yue-Ting Deng; Shi-Dong Chen; Qiang Dong; Jin-Tai Yu
Journal:  J Transl Med       Date:  2022-04-21       Impact factor: 5.531

Review 7.  Dysfunction and ceRNA network of the tumor suppressor miR-637 in cancer development and prognosis.

Authors:  Jinze Shen; Chenhao Liang; Xinming Su; Qurui Wang; Yufei Ke; Jie Fang; Dayong Zhang; Shiwei Duan
Journal:  Biomark Res       Date:  2022-09-30
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.